File and folder security is crucial in this day and age. There are apps you can use to heighten the security of your files. These apps are free and available for desktop and mobile devices. The need ...

London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as ...

PYC Therapeutics, a developer of RNA therapies for genetic diseases and capitalised at $933 million on the ASX, confirmed a $653 million equity raising on Monday morning after Street Talk revealed the ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

What's CODE SWITCH? It's the fearless conversations about race that you've been waiting for. Hosted by journalists of color, our podcast tackles the subject of race with empathy and humor. We explore ...

This raise will set the company up for years. With PYC's value sitting at $944.8 million at the close of trade on Friday, the raise will grow the size of the company by 69.2% in one fell swoop. The ...

The ASX 200 healthcare sector edged ahead of the broader market at the start of 2026, with the ASX 200 Healthcare Index (ASX:XHJ) rising 2.25% in January compared with a 1.78% gain in the ASX 200 (ASX ...

PYC Therapeutics Ltd. is a drug-development company, which provides a new generation of RNA therapeutics to meet unmet need in disease. It develops intracellular biological therapeutics including its ...